Heparin purification method
US4119774A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Mar 2, 1977 |
| Grant date | Oct 10, 1978 |
| Priority date | — |
| Expiry date | Mar 2, 1997 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08B37/0075
- WIPO fieldMacromolecular chemistry, polymers
- WIPO sectorChemistry
Abstract
Crude clinically used heparin preparations having a low specific activity, for example, about 130 heparin units per milligram are purified by contacting such liquid crude heparin preparations with a gel matrix complexed with (i.e. having linked to it) antithrombin or inter-alpha-trypsin inhibitor as a heparin-binding plasma protein, and then desorbing or eluting the heparin from the antithrombin or inter-alpha-trypsin inhibitor complexed gel matrix as with an applicable buffer, removing any salt in the solution with the heparin by gel filtration and then drying the heparin as by lyophilization.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.